Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...

A wellness influencer named Janelle Rohner has come under fire after withholding the fact that she was using a GLP-1 weight ...

A team of four mechanical engineering students from South Dakota State University took first place at NASA’s Blue Skies competition with their innovative drone prototypes.

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

A growing number of South Dakotans are shedding pounds thanks to GLP-1 medications, but now they’re hitting a roadblock.

Listen to Dr. Ilana Ressler explain PCOS and its significance in fertility and metabolic health on our latest episode.

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

Final overall survival (OS) results from the INAVO120 trial (NCT04191499) confirmed that the addition of inavolisib (Itovebi) ...

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...

A new study suggests GLP-1 class weight-loss drugs may lower cancer risk in people with diabetes. It looked at 170,000 patient records, and found there's a slightly lower risk of obesity-related ...